链连一叶萩碱二聚体和多聚体的合成研究

来源 :2015年全国药物化学学术会议暨第五届中英药物化学学术会议 | 被引量 : 0次 | 上传用户:ahphone
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  一叶萩型生物碱(Securinega alkaloid)是一类分布广泛,结构独特,具有众多生物活性的天然化合物。上个世纪中叶,第一个一叶萩型生物碱--一叶萩碱被分离得到,此后各国学者对一叶萩型生物碱进行了分离提取,全合成,结构修饰以及药理活性等多方面的研究。
其他文献
会议
Thrombin-binding DNA aptamer(TBA)can fold into an G-quadruplex structure necessary for interacting with thrombin.It is reported that incorporation the D-isothymidine(D-isoT)or unlocked nucleic acid(UN
The primary barrier of eradicating HIV virus is the existence of latent reservoirs.So it is urgent to look for effective activators of latent HIV and find out the activate mechanisms.The positive tran
The novel retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid(CD437/AHPN),which is RARγ agonist,can induces apoptosis in a number of malignant cell types [1-2].
Fragment-docking-oriented de novel design for the A,D and C site of protein tyrosine phosphatase 1B(PTP1B)and optimization led to the discovery of novel scaffold and chemical easy N-(2,5-diethoxy-phen
Aminopeptidase N(APN,EC 3.4.11.2)is highly expressed in tumor cells,and plays an essential role in tumor invasion,metastasis and angiogenesis.APN has been considered as a diagnostic or prognostic biom
Based on the strategy of “multifunctional drugs”,a novel series of phenylsulfonylfuroxan-based hydroxamates with histone deacetylase(HDAC)inhibitory and nitric oxide(NO)donating activities were design
依鲁替尼是一种新型Bruton 酪氨酸激酶(BTK)抑制剂,主要用来治疗套细胞淋巴瘤(MCL)和慢性淋巴细胞性白血病(CLL)。依鲁替尼能够阻断介导恶性B 细胞不可控地增殖和扩散的信号通路,不可逆地抑制Bruton 酪氨酸激酶的活性,有效抑制肿瘤细胞的增殖和存活。
Incorporating protein flexibility is a major challenge for docking-based virtual screening[1].With an increasing number of available crystal structures,ensemble docking with multiple protein structure
会议